I personally get out of biotecs if I can’t see they have enough capital to operate for the 12 mts ahead without taking into account any forecasts on what sales growths or approvals might eventuate . So many companies fall just short of getting their product to market due to underestimating what capital and how long it will take
Ann: Admedus Secures Strategic Investor, page-376
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.79 |
Change
-0.210(1.50%) |
Mkt cap ! $283.4M | |||
| Open | High | Low | Value | Volume |
| $14.00 | $14.23 | $13.30 | $117.7K | 8.476K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 288 | $13.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.96 | 406 | 1 |
View Market Depth
| Last trade - 12.01pm 07/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |